The role of suPAR and related proteins in kidney, heart diseases, and diabetes
Journal of Clinical Investigation · 02.01.2026 · 136 (1)
DOI: 10.1172/jci197141 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Investigation, online erschienen am 02.01.2026. Verfasst von Jochen Reiser und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine and. Hauptthemen laut MEDLINE: Receptors, Urokinase Plasminogen Activator, Immunity, Innate, Diabetes Mellitus, Type 1, Heart Diseases. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIH Office of the Director.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The urokinase plasminogen activator receptor (uPAR) is a membrane-bound protein found on the surface of immune cells. Through the action of proteases, uPAR is cleaved to produce several circulating proteins in the bloodstream, including the soluble form suPAR and the fragments D1 and D2D3. Initially studied in the context of infectious diseases and cancer, recent research has revealed roles for suPAR and its related proteins as mediators linking innate immunity to the pathogenesis of kidney and cardiovascular diseases, as well as insulin-dependent diabetes. While these proteins have long been recognized as prognostic biomarkers, growing clinical, experimental, and genetic evidence highlights their active involvement in the onset and progression of these diverse conditions. This Review examines suPAR’s evolution from its discovery as a modulator of innate immunity to its current status as a key driver in chronic kidney and cardiovascular diseases. Furthermore, we explore the molecular mechanisms through which suPAR and D2D3 contribute to multiorgan damage, emphasizing emerging opportunities for therapeutic interventions across interconnected organ systems.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine and.
- Sealy Institute for Drug Discovery, University of Texas Medical Branch, Galveston, Texas, USA.
Förderung
- NIDDK NIH HHS
- NIH Office of the Director
Zitieren
APA
Reiser, J., Hayek, S. S., & Sever, S. (2026). The role of suPAR and related proteins in kidney, heart diseases, and diabetes. Journal of Clinical Investigation, 136(1). https://doi.org/10.1172/jci197141
Vancouver
Reiser J, Hayek SS, Sever S. The role of suPAR and related proteins in kidney, heart diseases, and diabetes. Journal of Clinical Investigation. 2026;136(1). doi:10.1172/jci197141
BibTeX
@article{Reiser2026,
author = {Reiser, Jochen and Hayek, Salim S and Sever, Sanja},
title = {The role of suPAR and related proteins in kidney, heart diseases, and diabetes},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {1},
doi = {10.1172/jci197141}
}
EUVIMED